Ali Kiadaliri

Associate Professor, Associate Researcher, Docent, Doctoral Degree
More filtering options
  1. Cost-Effectiveness Analysis Of Cancer Treatments In South Of Iran

    Aliasghar Ahmad Kiadaliri, P. Bastani, N. Hatam & N. Ahmadloo, 2010, In: Value in Health. 13, 7, p. A267-A268

    Research output: Contribution to journalPublished meeting abstract

  2. QUALITY OF LIFE AFTER CHEMOTHERAPY IN BREAST CANCER: A STUDY IN SOUTH OF IRAN

    Aliasghar Ahmad Kiadaliri & P. Bastani, 2010, In: Value in Health. 13, 7, p. A277-A277

    Research output: Contribution to journalPublished meeting abstract

  3. Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.

    Aliasghar Ahmad Kiadaliri, Ulf Gerdtham, Björn Eliasson, Soffia Gudbjörnsdottir, Ann-Marie Svensson & Katarina Steen Carlsson, 2014, In: International Journal of Environmental Research and Public Health. 11, 5, p. 4939-4952

    Research output: Contribution to journalArticle

  4. Towards a Health Economic Simulation Model of Type 2 Diabetes in Sweden

    Aliasghar Ahmad Kiadaliri, 2014, Health Economics. 57 p.

    Research output: ThesisDoctoral Thesis (compilation)

  5. Quality of life in people with diabetes: a systematic review of studies in Iran.

    Aliasghar Ahmad Kiadaliri, Baharak Najafi & Maryam Mirmalek-Sani, 2013, In: Journal of Diabetes & Metabolic Disorders. 12, 1, 54.

    Research output: Contribution to journalReview article

  6. Overall, gender and social inequalities in suicide mortality in Iran, 2006-2010: a time trend province-level study.

    Aliasghar Ahmad Kiadaliri, Soheil Saadat, Hossein Shahnavazi & Hassan Haghparast-Bidgoli, 2014, In: BMJ Open. 4, 8, p. e005227

    Research output: Contribution to journalArticle

  7. Measuring Efficiency of General Hospitals in the South of Iran

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast-Bidgoli & Asghar Zarei, 2011, In: World Applied Sciences Journal. 13, 6, p. 1310-1316

    Research output: Contribution to journalArticle

  8. The prevalence of adulthood overweight and obesity in Tehran: findings from Urban HEART-2 study.

    Aliasghar Ahmad Kiadaliri, Mehdi Jafari, Mohammad-Reza Vaez Mahdavi, Soghrat Faghihzadeh, Naser Kalantari & Mohsen Asadi-Lari, 2015, In: Medical Journal of the Islamic Republic of Iran. 29, 178, p. 1-9

    Research output: Contribution to journalArticle

  9. Absolute and relative educational inequalities in obesity among adults in Tehran: Findings from the Urban HEART study-2.

    Aliasghar Ahmad Kiadaliri, Mohsen Asadi-Lari, Naser Kalantari, Mehdi Jafari, Mohammad Reza Vaez Mahdavi & Soghrat Faghihzadeh, 2015, In: Obesity Research and Clinical Practice.

    Research output: Contribution to journalArticle

  10. The impact of factor VIII inhibitors on factor consumption in haemophilia: a case-control study in the south of Iran

    Aliasghar Ahmad Kiadaliri, Kimia Pourmohammadi, Peivand Bastani & Mehran Karimi, 2011, In: Middle-East Journal of Scientific Research. 8, 3, p. 694-698

    Research output: Contribution to journalArticle

  11. Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast & Jahanara Mamikhani, 2009, International Journal of Technology Assessment in Health Care, 25, 4, p. 584-587.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  12. Technical efficiency of public hospitals in Khuzestan province, Iran

    Aliasghar Ahmad Kiadaliri & Asghar Zarei, 2009.

    Research output: Contribution to conferenceAbstract

  13. Geographical distribution of rural health houses in provinces of Iran.

    Aliasghar Ahmad Kiadaliri, Hassan Haghparast, Hamidreza Safari & Behzad Najafi, 2010.

    Research output: Contribution to conferenceAbstract

  14. Geographic Distribution of CCU beds in Iran.

    Aliasghar Ahmad Kiadaliri, Hamidreza Safari & Reza Hoseinpour, 2010.

    Research output: Contribution to conferenceAbstract

  15. The impact of inhibitors on the cost of clotting factor replacement therapy in hemophilia A in south of Iran.

    Aliasghar Ahmad Kiadaliri, M. Karimi, K. Pourmohammadi & P. Bastani, 2009.

    Research output: Contribution to conferenceAbstract

  16. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Maternal Mortality Collaborators GBD 2015 Maternal Mortality Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1775-1812 38 p.

    Research output: Contribution to journalArticle

  17. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Risk Factors Collaborators GBD 2015 Risk Factors Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1659-1724

    Research output: Contribution to journalArticle

  18. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 DALYs and HALE Collaborators GBD 2015 DALYs and HALE Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1603-1658 56 p.

    Research output: Contribution to journalArticle

  19. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1545-1602

    Research output: Contribution to journalArticle

  20. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

    GBD 2015 Mortality and Causes of Death Collaborators GBD 2015 Mortality and Causes of Death Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1459-1544 86 p.

    Research output: Contribution to journalArticle

  21. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

    Bo Norrving & GBD 2015 SDG Collaborators GBD 2015 SDG Collaborators, 2016 Oct 8, In: The Lancet. 388, 10053, p. 1813-1850

    Research output: Contribution to journalArticle

  22. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

    Global Burden of Disease Health Financing Collaborator Network Global Burden of Disease Health Financing Collaborator Network, 2017, In: The Lancet. 389, 10083, p. 2005-2030

    Research output: Contribution to journalArticle

  23. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

    Global Burden of Disease Health Financing Collaborator Network Global Burden of Disease Health Financing Collaborator Network, 2017, In: The Lancet. 389, 20-26, p. 1981-2004

    Research output: Contribution to journalArticle

  24. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015

    GBD 2015 Healthcare Access and Quality Collaborators GBD 2015 Healthcare Access and Quality Collaborators, 2017, In: The Lancet. 390, 10091, p. 231-266

    Research output: Contribution to journalArticle

  25. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Risk Factors Collaborators GBD 2016 Risk Factors Collaborators, 2017 Sep 16, In: The Lancet. 390, 10100, p. 1345-1422 78 p.

    Research output: Contribution to journalArticle

  26. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 DALYs and HALE Collaborators GBD 2016 DALYs and HALE Collaborators, 2017 Sep 16, In: The Lancet. 390, 10100, p. 1260-1344 85 p.

    Research output: Contribution to journalArticle

  27. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017 Sep 16, In: The Lancet. 390, 10100, p. 1211-1259 49 p.

    Research output: Contribution to journalArticle

  28. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Causes of Death Collaborators GBD 2016 Causes of Death Collaborators, 2017 Sep 16, In: The Lancet. 390, 10100, p. 1151-1210 60 p.

    Research output: Contribution to journalArticle

  29. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

    GBD 2016 Mortality Collaborators GBD 2016 Mortality Collaborators, 2017 Sep 16, In: The Lancet. 390, 10100, p. 1084-1150 67 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next